GROUP-II METABOTROPIC GLUTAMATE RECEPTOR LIGANDS AS ADJUNCTIVE DRUGS IN THE TREATMENT OF DEPRESSION: A NEW STRATEGY TO SHORTEN THE LATENCY OF ANTIDEPRESSANT MEDICATION?